))
Ep. 53 - Bob Nelsen on AI, China and the IRA
Manage episode 416017396 series 3571902
Sisällön tarjoaa BioCentury. BioCentury tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
This is a previously recorded episode of The BioCentury Show. Subscribe to this channel to listen to each new episode. Visit TheBioCenturyYouTube.com to access and watch all prior episodes.
In a wide-ranging conversation with BioCentury, Bob Nelsen, co-founder and managing director of Arch Venture Partners, said he is excited by the potential for AI to “create a language of biology,” is cautious about investing in China given increasing geopolitical tensions, and is convinced that the U.S. healthcare system could do a far better job of delivering on the promise of rapidly progressing science.
Nelsen, who has helped finance and create more than 150 companies, including 47 that have reached valuations exceeding $1 billion, discussed his conviction that focusing on creating transformational medicines, rather than looking for short-term gains, is a key to success in the life sciences.
View full story: https://www.biocentury.com/article/651502
#biotech #pharma #biopharma #TheBioCenturyShow
00:00 - Intro
02:00 - The Promise of AI
08:37 - The Inflation Reduction Act
15:50 - China
26:04 - Building Companies Around Big challenges
Luvut
1. Introduction (00:00:00)
2. The Promise of AI (00:02:00)
3. The Inflation Reduction Act (00:08:37)
4. China (00:15:50)
5. Building Companies Around Big challenges (00:26:04)
18 jaksoa
Jaa
